Skip to main content
Erschienen in: Clinical Rheumatology 5/2009

01.05.2009 | Original Article

Association of complementary or alternative medicine use with quality of life, functional status or cumulated damage in chronic rheumatic diseases

verfasst von: José Alvarez-Nemegyei, Alberta Bautista-Botello, Jorge Dávila-Velázquez

Erschienen in: Clinical Rheumatology | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Quality of life, functional status, or cumulated damage were compared between users and non-users of complementary and alternative medicine (CAM) in 445 rheumatic patients (rheumatoid arthritis [RA]: 64; systemic lupus erythematosus [SLE]: 192; fibromyalgia [FM]: 34; and knee osteoarthritis [KOA]: 155). CAM use was reported by 249 subjects (55.9%; 95%CI; 51.4–60.6). After a general linear model was applied, CAM use was associated with lower scores in the physical function (p = 0.02) and bodily pain (p = 0.03) domains of the SF-36 survey. In FM, RA and KOA, functional status was not different between users and non-users. CAM use was associated with higher cumulated damage (p = 0.04) in SLE. In patients with chronic rheumatic diseases, CAM use was not associated with better quality of life. Additionally, in SLE patients, CAM use was associated with higher cumulated damage. More research on CAM use in chronic rheumatic diseases is needed to better delineate its risk/benefit profile.
Literatur
2.
Zurück zum Zitat Eisenberg D, Kessler R, Van R, Kaptchuk T, Wilkey S, Appel S et al (2001) Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a National Survey. Ann Intern Med 135:344–351PubMed Eisenberg D, Kessler R, Van R, Kaptchuk T, Wilkey S, Appel S et al (2001) Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a National Survey. Ann Intern Med 135:344–351PubMed
3.
Zurück zum Zitat Eisenberg DM, Davis RB, Tener SL, Appel S, Wilkey S, van Rompay M et al (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280:1569–1575PubMedCrossRef Eisenberg DM, Davis RB, Tener SL, Appel S, Wilkey S, van Rompay M et al (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280:1569–1575PubMedCrossRef
4.
Zurück zum Zitat Desmet P (2002) Drug Therapy: herbal remedies. N Engl J Med 2002 2046–2056 Desmet P (2002) Drug Therapy: herbal remedies. N Engl J Med 2002 2046–2056
5.
Zurück zum Zitat Rao JK, Mihaliak K, Kroenke K, Bradley J, Tierney W, Weinberger M (2003) Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 131:409–416 Rao JK, Mihaliak K, Kroenke K, Bradley J, Tierney W, Weinberger M (2003) Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 131:409–416
7.
Zurück zum Zitat Lau CS, Lo Y, Mok MY (2001) The use of complementary and alternative medicines in rheumatic diseases in Chinese. Arthritis Care Res 45:S13 Lau CS, Lo Y, Mok MY (2001) The use of complementary and alternative medicines in rheumatic diseases in Chinese. Arthritis Care Res 45:S13
8.
Zurück zum Zitat Ramos-Remus C, Gamez-Nava JL, Gonzalez-López L et al (1998) Use of alternative therapies by patients with rheumatic diseases in Guadalajara, México: prevalence, believes and expectatives. Arthritis Care Res 11:411–418PubMedCrossRef Ramos-Remus C, Gamez-Nava JL, Gonzalez-López L et al (1998) Use of alternative therapies by patients with rheumatic diseases in Guadalajara, México: prevalence, believes and expectatives. Arthritis Care Res 11:411–418PubMedCrossRef
9.
Zurück zum Zitat Ramos-Remus C, Gutierrez-Urena S, Davis P (1999) Epidemiology of complementary and alternative practices in Rheumatology. Rheum Dis Clin North Am 25:789–804PubMedCrossRef Ramos-Remus C, Gutierrez-Urena S, Davis P (1999) Epidemiology of complementary and alternative practices in Rheumatology. Rheum Dis Clin North Am 25:789–804PubMedCrossRef
10.
Zurück zum Zitat Alvarez-Hernandez E, Casasola-Vargas JC, Lino-Perez L, Burgos-Vargas R, Vazquez-Mellado J (2006) Frecuencia de uso de medicinas complementarias y alternativas en sujetos que acuden por primera vez al servicio de reumatología. Análisis de 800 casos. [Frequency of use of complementary and alternative medicine in first-time patients of an outpatient rheumatology clinic. An analysis of 800 cases] [Spanish]. Reumatol Clin 2:183–189CrossRef Alvarez-Hernandez E, Casasola-Vargas JC, Lino-Perez L, Burgos-Vargas R, Vazquez-Mellado J (2006) Frecuencia de uso de medicinas complementarias y alternativas en sujetos que acuden por primera vez al servicio de reumatología. Análisis de 800 casos. [Frequency of use of complementary and alternative medicine in first-time patients of an outpatient rheumatology clinic. An analysis of 800 cases] [Spanish]. Reumatol Clin 2:183–189CrossRef
11.
Zurück zum Zitat Leong KP, Pong LY, Chan SP (2003) Why lupus patients use alternative medicine. Lupus 12:659–664PubMedCrossRef Leong KP, Pong LY, Chan SP (2003) Why lupus patients use alternative medicine. Lupus 12:659–664PubMedCrossRef
12.
Zurück zum Zitat Buchwald D (2003) Complementary and alternative medicine in fibromyalgia and related syndromes. Best Pract & Res Clin Rheumatol 17:667–683CrossRef Buchwald D (2003) Complementary and alternative medicine in fibromyalgia and related syndromes. Best Pract & Res Clin Rheumatol 17:667–683CrossRef
13.
Zurück zum Zitat Weiner D, Edzards E (2004) Complementary and alternative approaches to the treatment of persistent musculoskeletal pain. Clin J Pain 20:244–255PubMedCrossRef Weiner D, Edzards E (2004) Complementary and alternative approaches to the treatment of persistent musculoskeletal pain. Clin J Pain 20:244–255PubMedCrossRef
14.
Zurück zum Zitat Soeken K (2004) Selected CAM therapies for arthritis related pain: the evidence from systematic reviews. Clin J Pain 20:13–18PubMedCrossRef Soeken K (2004) Selected CAM therapies for arthritis related pain: the evidence from systematic reviews. Clin J Pain 20:13–18PubMedCrossRef
15.
Zurück zum Zitat Reginster J-Y, Bruyere O, Neuprez A (2007) Current role of glucosamine in the treatment of osteoarthritis. Rheumatology (Oxford) 46:731–735CrossRef Reginster J-Y, Bruyere O, Neuprez A (2007) Current role of glucosamine in the treatment of osteoarthritis. Rheumatology (Oxford) 46:731–735CrossRef
16.
Zurück zum Zitat Maheu E, Mazieres B, Valat JP et al (1998) Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect. Arthritis Rheum 41:81–91PubMedCrossRef Maheu E, Mazieres B, Valat JP et al (1998) Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect. Arthritis Rheum 41:81–91PubMedCrossRef
17.
Zurück zum Zitat van Vollenhoven RF (2002) Dehydroepiandrosterone for the treatment of systemic lupus erythematosus. Expert Opin Pharmacother 3:23–31PubMedCrossRef van Vollenhoven RF (2002) Dehydroepiandrosterone for the treatment of systemic lupus erythematosus. Expert Opin Pharmacother 3:23–31PubMedCrossRef
18.
Zurück zum Zitat Moore AD, Petri MA, Isenberg DA et al (2000) The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study Group. Arthritis Rheum 43:1410–1418PubMedCrossRef Moore AD, Petri MA, Isenberg DA et al (2000) The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study Group. Arthritis Rheum 43:1410–1418PubMedCrossRef
19.
Zurück zum Zitat Zochling J, March L, Lapsley H, Cross M, Tribe K, Brooks P (2004) Use of complementary medicines for osteoarthritis—a prospective study. Ann Rheum Dis 63:549–554PubMedCrossRef Zochling J, March L, Lapsley H, Cross M, Tribe K, Brooks P (2004) Use of complementary medicines for osteoarthritis—a prospective study. Ann Rheum Dis 63:549–554PubMedCrossRef
20.
Zurück zum Zitat Ramos-Remus C, Gamez-Nava JI, Gonzalez-Lopez L, Suarez-Almazor ME (1997) Use of alternative medicine in a consecutive sample of patients with systemic lupus erythematosus. [Letter] J Rheumatol 4:2490–2491 Ramos-Remus C, Gamez-Nava JI, Gonzalez-Lopez L, Suarez-Almazor ME (1997) Use of alternative medicine in a consecutive sample of patients with systemic lupus erythematosus. [Letter] J Rheumatol 4:2490–2491
21.
Zurück zum Zitat Angell M, Kassirer JP (1998) Alternative medicine. The risk of untested and unregulated remedies. New Engl J Med 339:839–841PubMedCrossRef Angell M, Kassirer JP (1998) Alternative medicine. The risk of untested and unregulated remedies. New Engl J Med 339:839–841PubMedCrossRef
22.
Zurück zum Zitat Arathi RS, Sigal LH (2005) Herbal medications commonly used in the practice of Rheumatology: mechanisms of action, efficacy and side effects. Semin Arthritis Rheum 34:773–784CrossRef Arathi RS, Sigal LH (2005) Herbal medications commonly used in the practice of Rheumatology: mechanisms of action, efficacy and side effects. Semin Arthritis Rheum 34:773–784CrossRef
23.
Zurück zum Zitat Hilepo JN, Belluci AG, Mossey RT (1997) Acute renal failure caused by “cat’s claw” herbal remedy in a patient with systemic lupus erythematosus. Nephron 77:361PubMedCrossRef Hilepo JN, Belluci AG, Mossey RT (1997) Acute renal failure caused by “cat’s claw” herbal remedy in a patient with systemic lupus erythematosus. Nephron 77:361PubMedCrossRef
24.
Zurück zum Zitat Kraus A, Guerra-Bautista G, Alarcon-Segovia D (1991) Salmonella arizona arthritis and septicemia associated with rattlesnake ingestion by patients with connective tissue diseases. A dangerous complication of folk medicine. J Rheumatol 18:1328–1331PubMed Kraus A, Guerra-Bautista G, Alarcon-Segovia D (1991) Salmonella arizona arthritis and septicemia associated with rattlesnake ingestion by patients with connective tissue diseases. A dangerous complication of folk medicine. J Rheumatol 18:1328–1331PubMed
25.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA et al (1998) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRef Arnett FC, Edworthy SM, Bloch DA et al (1998) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324CrossRef
26.
Zurück zum Zitat Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990. Criteria for the classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRef Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990. Criteria for the classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172PubMedCrossRef
27.
Zurück zum Zitat Altman RD, Ash E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis of knee. Arthritis Rheum 29:1039–1049PubMedCrossRef Altman RD, Ash E, Bloch D et al (1986) Development of criteria for the classification and reporting of osteoarthritis of knee. Arthritis Rheum 29:1039–1049PubMedCrossRef
28.
Zurück zum Zitat Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification for the Systemic Lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification for the Systemic Lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef
30.
Zurück zum Zitat Zúñiga M, Carrillo-Jiménez GT, Fos PJ, Gandek B, Medina-Moreno MR (1999) Evaluación del estado de salud con la encuesta SF-36: resultados preliminares en México [Health status assessment using the SF-36 survey: preliminary results in Mexico] (Spanish) Salud Pública Mex 41:110–118 Zúñiga M, Carrillo-Jiménez GT, Fos PJ, Gandek B, Medina-Moreno MR (1999) Evaluación del estado de salud con la encuesta SF-36: resultados preliminares en México [Health status assessment using the SF-36 survey: preliminary results in Mexico] (Spanish) Salud Pública Mex 41:110–118
31.
Zurück zum Zitat Cardiel MH, Abello-Banfi M, Ruiz-Mercado R (1993) How to measure health status in rheumatoid arthritis in non-English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI). Clin Exp Rheumatol 11:117–121PubMed Cardiel MH, Abello-Banfi M, Ruiz-Mercado R (1993) How to measure health status in rheumatoid arthritis in non-English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI). Clin Exp Rheumatol 11:117–121PubMed
32.
Zurück zum Zitat Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728–733PubMed Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728–733PubMed
33.
Zurück zum Zitat Martínez-Rueda JO, Gonzalez-Sánchez CB, Hernández-Alonzo E (1995) Desarrollo y evaluación de la sensibilidad al cambio de una versión corta del Fibromyalgia Impact Questionnaire (FIQ). [Development and change sensitivity assessment of a short version of the Fibromyalgia Impact Questionnaire (FIQ)] (Spanish) Rev Mex Reumatol Suppl 1;P1 Martínez-Rueda JO, Gonzalez-Sánchez CB, Hernández-Alonzo E (1995) Desarrollo y evaluación de la sensibilidad al cambio de una versión corta del Fibromyalgia Impact Questionnaire (FIQ). [Development and change sensitivity assessment of a short version of the Fibromyalgia Impact Questionnaire (FIQ)] (Spanish) Rev Mex Reumatol Suppl 1;P1
34.
Zurück zum Zitat Bellamy N, Buchanan WW, Goldsmith CH (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip and knee. J Rheumatol 15:1833–1840PubMed Bellamy N, Buchanan WW, Goldsmith CH (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip and knee. J Rheumatol 15:1833–1840PubMed
35.
Zurück zum Zitat Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for Systemic Lupus Erythematosus. Arthritis Rheum 39:363–369PubMedCrossRef Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for Systemic Lupus Erythematosus. Arthritis Rheum 39:363–369PubMedCrossRef
Metadaten
Titel
Association of complementary or alternative medicine use with quality of life, functional status or cumulated damage in chronic rheumatic diseases
verfasst von
José Alvarez-Nemegyei
Alberta Bautista-Botello
Jorge Dávila-Velázquez
Publikationsdatum
01.05.2009
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 5/2009
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-1082-y

Weitere Artikel der Ausgabe 5/2009

Clinical Rheumatology 5/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.